Ildong Holdings Co., Ltd. (000230.KS)
KRW 6600.0
(-5.44%)
KRW 6600.0
(-5.44%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 382.06 Billion KRW | 20.1% |
| 2022 | 318.12 Billion KRW | -1.84% |
| 2021 | 324.09 Billion KRW | 32.76% |
| 2020 | 244.12 Billion KRW | 3.77% |
| 2019 | 235.25 Billion KRW | 249.19% |
| 2018 | 67.37 Billion KRW | 2.03% |
| 2017 | 66.03 Billion KRW | 3.83% |
| 2016 | 63.59 Billion KRW | -66.79% |
| 2015 | 191.51 Billion KRW | 32.69% |
| 2014 | 144.33 Billion KRW | -13.43% |
| 2013 | 166.71 Billion KRW | 80.04% |
| 2012 | 92.6 Billion KRW | 12.79% |
| 2011 | 82.1 Billion KRW | -41.2% |
| 2010 | 139.62 Billion KRW | 9.61% |
| 2009 | 127.38 Billion KRW | 12.22% |
| 2008 | 113.52 Billion KRW | 89.37% |
| 2007 | 59.94 Billion KRW | 42.43% |
| 2006 | 42.08 Billion KRW | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 380.9 Billion KRW | -0.3% |
| 2024 Q2 | 383.2 Billion KRW | 0.61% |
| 2023 Q4 | 382.06 Billion KRW | 6.37% |
| 2023 Q1 | 321.68 Billion KRW | 1.12% |
| 2023 Q2 | 363.92 Billion KRW | 13.13% |
| 2023 FY | 382.06 Billion KRW | 20.1% |
| 2023 Q3 | 359.17 Billion KRW | -1.31% |
| 2022 Q3 | 289.54 Billion KRW | -0.09% |
| 2022 Q1 | 288.19 Billion KRW | -11.08% |
| 2022 FY | 318.12 Billion KRW | -1.84% |
| 2022 Q4 | 318.12 Billion KRW | 9.87% |
| 2022 Q2 | 289.79 Billion KRW | 0.56% |
| 2021 Q1 | 309.22 Billion KRW | 26.66% |
| 2021 FY | 324.09 Billion KRW | 32.76% |
| 2021 Q4 | 324.09 Billion KRW | 6.91% |
| 2021 Q3 | 303.15 Billion KRW | 0.93% |
| 2021 Q2 | 300.36 Billion KRW | -2.87% |
| 2020 Q2 | 244.33 Billion KRW | 0.94% |
| 2020 Q1 | 242.05 Billion KRW | 2.89% |
| 2020 FY | 244.12 Billion KRW | 3.77% |
| 2020 Q3 | 246.53 Billion KRW | 0.9% |
| 2020 Q4 | 244.12 Billion KRW | -0.98% |
| 2019 FY | 235.25 Billion KRW | 249.19% |
| 2019 Q4 | 235.25 Billion KRW | -1.16% |
| 2019 Q2 | 69.37 Billion KRW | 1.45% |
| 2019 Q1 | 68.39 Billion KRW | 1.51% |
| 2019 Q3 | 238.02 Billion KRW | 243.07% |
| 2018 Q2 | 66.51 Billion KRW | 0.31% |
| 2018 Q1 | 66.3 Billion KRW | 0.42% |
| 2018 FY | 67.37 Billion KRW | 2.03% |
| 2018 Q4 | 67.37 Billion KRW | 0.52% |
| 2018 Q3 | 67.01 Billion KRW | 0.76% |
| 2017 Q4 | 66.03 Billion KRW | 0.89% |
| 2017 FY | 66.03 Billion KRW | 3.83% |
| 2017 Q1 | 49.09 Billion KRW | -22.8% |
| 2017 Q2 | 15.06 Billion KRW | -69.32% |
| 2017 Q3 | 65.44 Billion KRW | 334.43% |
| 2016 Q1 | 191.5 Billion KRW | -0.0% |
| 2016 Q4 | 63.59 Billion KRW | 4.09% |
| 2016 Q3 | 61.09 Billion KRW | 0.0% |
| 2016 Q2 | - KRW | -100.0% |
| 2016 FY | 63.59 Billion KRW | -66.79% |
| 2015 Q4 | 191.51 Billion KRW | 27.99% |
| 2015 FY | 191.51 Billion KRW | 32.69% |
| 2015 Q3 | 149.63 Billion KRW | 3.4% |
| 2015 Q2 | 144.71 Billion KRW | -1.74% |
| 2015 Q1 | 147.27 Billion KRW | 2.04% |
| 2014 FY | 144.33 Billion KRW | -13.43% |
| 2014 Q4 | 144.33 Billion KRW | -6.82% |
| 2014 Q3 | 154.9 Billion KRW | 0.73% |
| 2014 Q2 | 153.77 Billion KRW | 0.48% |
| 2014 Q1 | 153.03 Billion KRW | -8.2% |
| 2013 Q4 | 166.71 Billion KRW | 3.21% |
| 2013 FY | 166.71 Billion KRW | 80.04% |
| 2013 Q3 | 161.52 Billion KRW | -3.54% |
| 2013 Q1 | 110.05 Billion KRW | 18.84% |
| 2013 Q2 | 167.45 Billion KRW | 52.16% |
| 2012 FY | 92.6 Billion KRW | 12.79% |
| 2012 Q4 | 92.6 Billion KRW | 0.0% |
| 2012 Q1 | 84 Billion KRW | 0.0% |
| 2011 Q1 | 90.25 Billion KRW | 0.0% |
| 2011 Q2 | 87.08 Billion KRW | -3.51% |
| 2011 Q3 | 85.32 Billion KRW | -2.01% |
| 2011 FY | 82.1 Billion KRW | -41.2% |
| 2010 Q2 | 90.5 Billion KRW | 0.0% |
| 2010 Q3 | 90.5 Billion KRW | 0.0% |
| 2010 FY | 139.62 Billion KRW | 9.61% |
| 2009 Q4 | 92.61 Billion KRW | 1.17% |
| 2009 Q3 | 91.54 Billion KRW | 20.23% |
| 2009 FY | 127.38 Billion KRW | 12.22% |
| 2009 Q2 | 76.13 Billion KRW | 0.0% |
| 2008 Q4 | 48.52 Billion KRW | 1.81% |
| 2008 Q2 | 42.73 Billion KRW | 0.0% |
| 2008 Q3 | 47.66 Billion KRW | 11.53% |
| 2008 FY | 113.52 Billion KRW | 89.37% |
| 2007 FY | 59.94 Billion KRW | 42.43% |
| 2007 Q2 | 36.02 Billion KRW | 0.0% |
| 2007 Q4 | 37.74 Billion KRW | 7.33% |
| 2007 Q3 | 35.16 Billion KRW | -2.38% |
| 2006 FY | 42.08 Billion KRW | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 39.4 Billion KRW | -869.52% |
| Dong-A Socio Holdings Co., Ltd. | 691.88 Billion KRW | 44.78% |
| HANDOK Inc. | 300.01 Billion KRW | -27.349% |
| Kukje Pharma Co., Ltd. | 30.66 Billion KRW | -1146.035% |
| Yuhan Corporation | 230.07 Billion KRW | -66.062% |
| Dong-A ST Co., Ltd. | 406.7 Billion KRW | 6.06% |
| SAMSUNG PHARM. Co., LTD. | 595.48 Million KRW | -64059.435% |
| Hanmi Pharm. Co., Ltd. | 572.86 Billion KRW | 33.307% |
| Hanall Biopharma Co.,Ltd | 1.29 Billion KRW | -29504.921% |
| Ilyang Pharmaceutical Co.,Ltd | 85.15 Billion KRW | -348.639% |
| Dong Sung Bio Pharm.Co.,Ltd. | 43.27 Billion KRW | -782.911% |
| MYUNGMOON Pharm co.,Ltd | 90.48 Billion KRW | -322.249% |
| Hana Pharm Co., Ltd. | 26.53 Billion KRW | -1339.94% |
| Yuyu Pharma, Inc. | 39.4 Billion KRW | -869.52% |
| Ilsung Pharmaceuticals Co., Ltd. | 238.12 Million KRW | -160344.595% |
| REYON Pharmaceutical Co., Ltd. | 225.05 Billion KRW | -69.764% |
| Aprogen pharmaceuticals,Inc. | 180.99 Billion KRW | -111.086% |
| JW Holdings Corporation | 554.58 Billion KRW | 31.109% |
| Ildong Pharmaceutical Co., Ltd. | 217.84 Billion KRW | -75.385% |
| Chong Kun Dang Pharmaceutical Corp. | 219.76 Billion KRW | -73.85% |
| JW Pharmaceutical Corporation | 170.28 Billion KRW | -124.371% |
| Shin Poong Pharm.Co.,Ltd. | 46.15 Billion KRW | -727.84% |
| Hyundai Pharmaceutical Co., Ltd. | 39.2 Billion KRW | -874.521% |
| Samil Pharmaceutical Co.,Ltd | 175.87 Billion KRW | -117.229% |
| Jeil Pharmaceutical Co.,Ltd | 84.96 Billion KRW | -349.665% |
| Yuyu Pharma, Inc. | 39.4 Billion KRW | -869.52% |
| Kwang Dong Pharmaceutical Co., Ltd. | 235.64 Billion KRW | -62.136% |
| Daewoong pharmaceutical Co.,Ltd | 469.68 Billion KRW | 18.656% |
| JW Pharmaceutical Corporation | 170.28 Billion KRW | -124.371% |
| Yuhan Corporation | 230.07 Billion KRW | -66.062% |
| Jeil Pharma Holdings Inc | 173.03 Billion KRW | -120.805% |
| Yungjin Pharm. Co., Ltd. | 66.88 Billion KRW | -471.245% |
| Suheung Co., Ltd. | 467.85 Billion KRW | 18.338% |
| JW Pharmaceutical Corporation | 170.28 Billion KRW | -124.371% |
| Samjin Pharmaceuticals Co., Ltd. | 118.63 Billion KRW | -222.038% |
| Korea United Pharm Inc. | 40.33 Billion KRW | -847.123% |
| CKD Bio Corp. | 146.92 Billion KRW | -160.035% |
| Daewon Pharmaceutical Co., Ltd. | 146.04 Billion KRW | -161.596% |
| Dongwha Pharm.Co.,Ltd | 48.25 Billion KRW | -691.747% |
| Whan In Pharm Co.,Ltd. | 632.02 Million KRW | -60350.137% |
| Shin Poong Pharm.Co.,Ltd. | 46.15 Billion KRW | -727.84% |
| Chong Kun Dang Holdings Corp. | 468.03 Billion KRW | 18.369% |
| Boryung Corporation | 204.21 Billion KRW | -87.087% |
| Bukwang Pharmaceutical Co., Ltd. | 79.38 Billion KRW | -381.264% |
| Ilyang Pharmaceutical Co.,Ltd | 85.15 Billion KRW | -348.639% |
| JW Lifescience Corporation | 46.31 Billion KRW | -724.956% |